Monopar Therapeutics Inc. Basic Shares Outstanding (Weighted Average)
Monopar Therapeutics Inc. (MNPR) reported Basic Shares Outstanding (Weighted Average) of 8.54 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- Monopar Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 8.54M shares, a 22.07% increase year-over-year.
- Monopar Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 8.54M shares, a 22.16% increase year-over-year.
- Monopar Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 8.53M shares, a 74.06% increase year-over-year.
- Monopar Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 7.12M shares, a 102.36% increase year-over-year.
- Monopar Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 7.41M shares, a 95.53% increase from fiscal 2024.
- Monopar Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 3.79M shares, a 37.09% increase from fiscal 2023.
- Monopar Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 2.76M shares, a 78.26% decline from fiscal 2022.
- Monopar Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 12.72M shares, a 1.98% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 8.54M shares 10-Q · filed 2026-08-12 | 8.54M shares 10-Q · filed 2026-08-12 | 8.54M shares derived: average of 3 quarters · filed 2026-08-12 | 8.18M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | 8.54M shares 10-Q · filed 2026-05-14 | 8.53M shares derived: average of 2 quarters · filed 2026-05-14 | 8.06M shares derived: average of 3 quarters · filed 2026-05-14 | 7.80M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | 8.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | 7.83M shares derived: average of 2 quarters · filed 2026-03-27 | 7.55M shares derived: average of 3 quarters · filed 2026-08-12 | 7.41M shares 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | 7.12M shares 10-Q · filed 2025-11-13 | 7.06M shares derived: average of 2 quarters · filed 2026-08-12 | 7.04M shares 10-Q · filed 2025-11-13 | 6.50M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | 7.00M shares 10-Q · filed 2026-08-12 | 6.99M shares 10-Q · filed 2026-08-12 | 6.30M shares derived: average of 3 quarters · filed 2026-08-12 | 5.60M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | 6.99M shares 10-Q · filed 2026-05-14 | 5.95M shares derived: average of 2 quarters · filed 2026-05-14 | 5.14M shares derived: average of 3 quarters · filed 2026-05-14 | 4.73M shares derived: average of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | 4.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | 4.21M shares derived: average of 2 quarters · filed 2026-03-27 | 3.98M shares derived: average of 3 quarters · filed 2026-03-27 | 3.79M shares 10-K · filed 2026-03-27 | ||||
| 2024-09-30 | 3.52M shares 10-Q · filed 2025-11-13 | 3.51M shares derived: average of 2 quarters · filed 2025-11-13 | 3.42M shares 10-Q · filed 2025-11-13 | 3.29M shares derived: average of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | 3.50M shares 10-Q · filed 2025-08-12 | 17.51M shares 10-Q · filed 2024-08-09 | 3.35M shares 10-Q · filed 2025-08-12 | 16.75M shares 10-Q · filed 2024-08-09 | 3.21M shares derived: average of 3 quarters · filed 2025-08-12 | 3.11M shares derived: average of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | 3.20M shares 10-Q · filed 2025-05-13 | 15.98M shares 10-Q · filed 2024-05-09 | 3.06M shares derived: average of 2 quarters · filed 2025-05-13 | 2.98M shares derived: average of 3 quarters · filed 2025-05-13 | 5.59M shares derived: average of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | 2.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 2.88M shares derived: average of 2 quarters · filed 2025-03-31 | 6.39M shares derived: average of 3 quarters · filed 2025-03-31 | 2.76M shares 10-K · filed 2025-03-31 | 13.82M shares 10-K · filed 2024-03-28 | |||
| 2023-09-30 | 2.82M shares 10-Q · filed 2024-11-08 | 14.12M shares 10-Q · filed 2023-11-09 | 8.12M shares derived: average of 2 quarters · filed 2024-11-08 | 2.71M shares 10-Q · filed 2024-11-08 | 13.55M shares 10-Q · filed 2023-11-09 | 10.56M shares derived: average of 4 quarters · filed 2024-11-08 | ||
| 2023-06-30 | 13.42M shares 10-Q · filed 2024-08-09 | 13.26M shares 10-Q · filed 2024-08-09 | 13.14M shares derived: average of 3 quarters · filed 2024-08-09 | 13.04M shares derived: average of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | 13.11M shares 10-Q · filed 2024-05-09 | 12.99M shares derived: average of 2 quarters · filed 2024-05-09 | 12.91M shares derived: average of 3 quarters · filed 2024-05-09 | 12.84M shares derived: average of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | 12.88M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 12.82M shares derived: average of 2 quarters · filed 2024-03-28 | 12.76M shares derived: average of 3 quarters · filed 2024-03-28 | 12.72M shares 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | 12.75M shares 10-Q · filed 2023-11-09 | 12.69M shares derived: average of 2 quarters · filed 2023-11-09 | 12.66M shares 10-Q · filed 2023-11-09 | |||||
| 2022-06-30 | 12.63M shares 10-Q · filed 2023-08-10 | 12.62M shares 10-Q · filed 2023-08-10 | ||||||
| 2021-12-31 | 12.47M shares 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |